• Home
  • About Us
  • Our Team
  • Our Portfolio
  • Our Insights
image 1828
Contact Us

Day: October 25, 2025

T-knife Therapeutics Announces $110 MillionSeries B Financing to Advance Pipeline…

Plan to initiate the IMAG1NE Phase 1/2 clinical study of TK-8001, a TCR-T cell therapy
for MAGE-A1 positive solid tumors, in 2021 August 02, 2021 08:00 ET…

Sixty Degree Capital Celebrates Final Close ofFund III, Raising $250M for VC Investment…

November 23, 2023 – Sixty Degree Capital is excited to announce the final close of
its third venture capital fund, with $250M earmarked for high-growth…

Eclypsium Raises $45M To Lock DownSupply-Chain Security

Portland, OR – January 28, 2025 (FORBES) Fans of The Big Lebowski know the
movie’s narrator introduces the protagonist as “the man for this time…

Eclypsium Raises $45M To Lock DownSupply-Chain Security

Eclypsium Raises $45M To Lock Down
Supply-Chain Security

CinCor Pharma to be Acquiredby AstraZeneca

CinCor Pharma to be Acquired
by AstraZeneca

Everside Health Announces $164Million in Growth Equity…

Everside Health Announces $164
Million in Growth Equity…

Join the conversation.

Follow us on social media to stay on top of the latest news and insights from Sixty Degree Capital.

Linkedin
Quick Links
Home
About Us
Our Team
Our Portfolio
Our Insights
Contact Us
Contact Us
info@sixtydegreecapital.com
251 Consumers Rd, North York Ontario M2J 4R3, Canada

© 2025, Sixty Degree Capital. All Rights Reserved.